Archives

Drug donanemab hailed as breakthrough in treat Alzheimer’s disease following trial

19 July 2023

A new drug has been hailed as a scientific breakthrough in treating Alzheimer’s disease, following the publication of final trial results in the medical journal, JAMA.  The findings show donanemab can successfully slow down decline in memory and thinking by 35 per cent among people with early-stage Alzheimer’s Disease. The drug’s ability to slow down […]

Breakthrough Alzheimer’s drug approved in the US

8 June 2021

MRI brain scan images

The US Food and Drug Administration (FDA) has this week approved the first drug since 2003 to treat Alzheimer’s disease. Aducanumab, created by US pharmaceutical company Biogen, is an antibody designed to target amyloid, a protein that builds up in the brains of people with early stages of Alzheimer’s disease. Whereas other existing treatments help […]

Alzheimer’s drug study restarts

23 November 2020

microscope with lab glassware

An Alzheimer’s drug study is restarting after being paused earlier this year. The CLARITY study is examining whether the drug BAN2401 can be effective in preventing or delaying the very early stages of Alzheimer’s disease.  Alzheimer’s disease affects approximately 26 million people worldwide and current medications only provide a temporary improvement in symptoms. Who can […]

The ‘AFFECT’ Study

26 February 2016

The ‘AFFECT’ study is the first large-scale research study that is a collaboration between researchers in Northern Ireland, and staff at the Dementias and Neurodegenerative Specialty  in England. It is also being jointly funded by the Alzheimer’s Society and British Heart Foundation. Did you know that after Alzheimer’s Disease, Vascular Dementia is the most common […]

The Gantenerumab Trial

This study looks at an exciting opportunity to get involved in testing  new medication for people with Alzheimer’s Disease. Aims of the Study Alzheimer’s disease is a major global public health problem, and there are nearly 30 million people with the disease worldwide. Alzheimer’s disease is an irreversible, progressive neurodegenerative disease which causes a gradual […]

get_header(); ?>

Archives